Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
24 participants
INTERVENTIONAL
2012-02-29
2012-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ephedrine
Ephedrine
An infusion with a maximum of 3 mg/minute for maximum 60 minutes or if sideeffects develope.
Phenylephrine
Phenylephrine
An infusion of maximum 4 mg/hour for maximum 60 minutes.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ephedrine
An infusion with a maximum of 3 mg/minute for maximum 60 minutes or if sideeffects develope.
Phenylephrine
An infusion of maximum 4 mg/hour for maximum 60 minutes.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Over 18 years old
* ASA 1-2
* Undergoing elective caesarean section
* Height over 160 cm or under 180 cm
Exclusion Criteria
* High blood levels of bilirubin
* HELPP syndrome
* Preeclampsia (pregnancy-induced hypertension)
* Non singleton pregnancies
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Rigshospitalet, Denmark
OTHER
Naestved Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Visti Foss
Principal Investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Visti Foss
Role: PRINCIPAL_INVESTIGATOR
Naestved Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Naestved Hospital
Næstved, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Chooi C, Cox JJ, Lumb RS, Middleton P, Chemali M, Emmett RS, Simmons SW, Cyna AM. Techniques for preventing hypotension during spinal anaesthesia for caesarean section. Cochrane Database Syst Rev. 2020 Jul 1;7(7):CD002251. doi: 10.1002/14651858.CD002251.pub4.
Foss VT, Christensen R, Rokamp KZ, Nissen P, Secher NH, Nielsen HB. Effect of phenylephrine vs. ephedrine on frontal lobe oxygenation during caesarean section with spinal anesthesia: an open label randomized controlled trial. Front Physiol. 2014 Mar 3;5:81. doi: 10.3389/fphys.2014.00081. eCollection 2014.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SJ-271
Identifier Type: OTHER
Identifier Source: secondary_id
2011-006103-35
Identifier Type: -
Identifier Source: org_study_id